BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24187332)

  • 1. Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis.
    Inoue HK; Sato H; Seto K; Torikai K; Suzuki Y; Saitoh J; Noda SE; Nakano T
    J Radiat Res; 2014 Mar; 55(2):334-42. PubMed ID: 24187332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and volumetric predictors of local control after robotic stereotactic radiosurgery for cerebral metastases: active systemic disease may affect local control in the brain.
    Blamek S; Stankiewicz M; Maciejewski B
    Radiol Oncol; 2020 Nov; 55(1):82-87. PubMed ID: 33885238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two fractions staged Gammaknife radiosurgery for "large" cerebral metastases.
    Borius PY; Amelot A; Boustany E; Boskos C; Mazeron JJ; Valéry CA
    Eur J Surg Oncol; 2023 Nov; 49(11):107043. PubMed ID: 37856987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concurrent antibody-drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study.
    Koide Y; Nagai N; Adachi S; Ito M; Kawamura M; Ito M; Ito F; Shindo Y; Aoyama T; Shimizu H; Hashimoto S; Tachibana H; Kodaira T
    J Neurooncol; 2024 Jul; 168(3):415-423. PubMed ID: 38644464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
    Makranz C; Lubotzky A; Zemmour H; Shemer R; Glaser B; Cohen J; Maoz M; Sapir E; Wygoda M; Peretz T; Weizman N; Feldman J; Abrams RA; Lossos A; Dor Y; Zick A
    PLoS One; 2023; 18(11):e0285646. PubMed ID: 38015964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Radiosensitive Diffuse Large B-cell Lymphoma of the Skull Treated With Low-Dose CyberKnife Radiotherapy: A Case Report.
    Mizumatsu S; Nomura R
    Cureus; 2023 Dec; 15(12):e51227. PubMed ID: 38283496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases.
    Lebow ES; Pike LRG; Seidman AD; Moss N; Beal K; Yu Y
    JAMA Oncol; 2023 Dec; 9(12):1729-1733. PubMed ID: 37883079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pectoralis Major Radiation Myonecrosis After Lung Stereotactic Body Radiation Therapy.
    Gurewitz J; Mahadevan A; Cooper BT
    Pract Radiat Oncol; 2024; 14(3):189-195. PubMed ID: 38163632
    [No Abstract]   [Full Text] [Related]  

  • 9. The Benefits of a Rapid Access Pathway for Patients Requiring Single Fraction Radiotherapy Treatment: The Cambridge Experience.
    Gatfield ER; Harvey C; Hayler M; Archer S; Chapman J; Chantler H; Ajithkumar T
    Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):e237-e238. PubMed ID: 38702242
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Radiotherapy strategies for precise treatment on brain metastases.
    Lehrer EJ; Breen WG; Sener U; Campian JL
    Front Oncol; 2024; 14():1366261. PubMed ID: 38571498
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study.
    Inoue HK; Sato H; Suzuki Y; Saitoh J; Noda SE; Seto K; Torikai K; Sakurai H; Nakano T
    Radiat Oncol; 2014 Oct; 9():231. PubMed ID: 25322826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated stereotactic radiosurgery for patients with brain metastases.
    Minniti G; D'Angelillo RM; Scaringi C; Trodella LE; Clarke E; Matteucci P; Osti MF; Ramella S; Enrici RM; Trodella L
    J Neurooncol; 2014 Apr; 117(2):295-301. PubMed ID: 24488446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.
    El Shafie RA; Paul A; Bernhardt D; Hauswald H; Welzel T; Sprave T; Hommertgen A; Krisam J; Schmitt D; Klüter S; Schubert K; Klose C; Kieser M; Debus J; Rieken S
    Neurosurgery; 2018 Sep; 83(3):566-573. PubMed ID: 29528419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
    Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.
    Bauman G; Yartsev S; Roberge D; MacRae R; Roa W; Panet-Raymond V; Masucci L; Yaremko B; D'Souza D; Palma D; Sexton T; Yu E; Pantarotto JR; Ahmad B; Fisher B; Dar AR; Lambert C; Pond G; Stitt L; Tay KY; Rodrigues G
    J Neurooncol; 2016 Jul; 128(3):431-6. PubMed ID: 27084705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target volume geometric change and/or deviation from the cranium during fractionated stereotactic radiotherapy for brain metastases: potential pitfalls in image guidance based on bony anatomy alignment.
    Ohtakara K; Hoshi H
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):729-36. PubMed ID: 24935347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway.
    Minniti G; Esposito V; Clarke E; Scaringi C; Bozzao A; Falco T; De Sanctis V; Enrici MM; Valeriani M; Osti MF; Enrici RM
    Radiat Oncol; 2014 May; 9():110. PubMed ID: 24886280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases.
    Ahmed KA; Sarangkasiri S; Chinnaiyan P; Sahebjam S; Yu HH; Etame AB; Rao NG
    Am J Clin Oncol; 2016 Aug; 39(4):379-83. PubMed ID: 24755663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
    Yamamoto M; Serizawa T; Shuto T; Akabane A; Higuchi Y; Kawagishi J; Yamanaka K; Sato Y; Jokura H; Yomo S; Nagano O; Kenai H; Moriki A; Suzuki S; Kida Y; Iwai Y; Hayashi M; Onishi H; Gondo M; Sato M; Akimitsu T; Kubo K; Kikuchi Y; Shibasaki T; Goto T; Takanashi M; Mori Y; Takakura K; Saeki N; Kunieda E; Aoyama H; Momoshima S; Tsuchiya K
    Lancet Oncol; 2014 Apr; 15(4):387-95. PubMed ID: 24621620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.